Taiwan FDA registration b578621459fd11ccfd0759b6448c681e

Beveili Enhanced Platelet Concentrate Separation Tube

TW: 倍威立加強型血小板濃縮液分離管

Taiwan·Risk Class 2·TCM BIOTECH INTERNATIONAL CORP.·Registered Mar 17, 2020 – Jun 20, 2028Active

Registration details

Analysis ID: b578621459fd11ccfd0759b6448c681e

Company information

Manufacturer: TCM BIOTECH INTERNATIONAL CORP.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: TCM BIOTECH INTERNATIONAL CORP.

Product details

Intended Use: The efficacy is changed to: this product uses vacuum blood collection to draw a small amount of peripheral blood from patients, and centrifuge to prepare platelet-rich plasma (PRP).
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.9245 Automated hemocytoseparator
Import Information: Domestic;; Contract manufacturing

Dates and status

Registration Date: Mar 17, 2020
Expiry Date: Jun 20, 2028

About this record

Access comprehensive regulatory information for Beveili Enhanced Platelet Concentrate Separation Tube in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b578621459fd11ccfd0759b6448c681e and manufactured by TCM BIOTECH INTERNATIONAL CORP.. The authorized representative in Taiwan is TCM BIOTECH INTERNATIONAL CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.